Success Story: NIW Approved for an Analytical Chemistry Researcher Advancing Separation Methods for Biomolecule Characterization
Client’s Testimonial:
“Thank you for working with me for these two years to finalize this case. I’m glad to see the result back as we expected.”
On January 9th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a PhD student, Teaching Assistant & Research Assistant in the Field of Analytical Chemistry (Approval Notice).
General Field: Analytical Chemistry
Position at the Time of Case Filing: PhD student, Teaching Assistant & Research Assistant
Country of Origin: Taiwan
State of Residence at the Time of Case Filing: Wisconsin
Approval Notice Date: January 9th, 2026
Processing Time: 22 months, 2 days (Premium Processing Upgrade Requested)
Case Summary:
North America Immigration Law Group (NAILG) is pleased to announce the approval of an I-140 EB-2 National Interest Waiver (NIW) petition for the client, an analytical chemistry researcher with an M.Sc. in chemistry. In this case, we positioned the client’s work around a clear national need: improving how bio-specimens and biomolecules are separated, enriched, and characterized so researchers and clinicians can better understand disease mechanisms and strengthen diagnostic decision-making. The petition also described that the client is currently conducting research in analytical chemistry in a U.S. university setting, supporting a strong forward-looking case that the client is actively positioned to continue advancing this work in the United States.
As an expert in the field of analytical chemistry, the client’s proposed endeavor is to continue developing novel separation and enrichment methods using chemical approaches to facilitate the characterization of bio-specimens and biomolecules. We framed this endeavor as an area of substantial merit and national importance because better molecular characterization can enable more accurate disease detection, improve diagnostic workflows, and strengthen the scientific basis for understanding disease mechanisms. Rather than relying on broad claims, the petition explained how advances in separation and enrichment methods create practical tools that other researchers can adopt for biomarker discovery and related diagnostic applications.
To demonstrate that the client is well-positioned to advance the endeavor, we emphasized objective evidence of research output and independent uptake. At the time of filing, the client had authored 4 peer-reviewed journal articles, including 1 first-authored publication, and held 1 patent. The client’s work had been cited 61 times. We did not present these metrics as automatically sufficient. Instead, we explained how an adjudicator could reasonably interpret the citation record as evidence of independent reliance, meaning other researchers found the client’s methods and findings useful enough to incorporate into their own work. We also provided context by highlighting that certain publications performed strongly relative to others in chemistry for their publication years, which helped translate the citation record into clearer evidence of influence beyond raw totals.
The petition was further supported by 2 letters of recommendation from experts in the field. These letters helped translate technical contributions into clear significance and corroborated the objective record by explaining why the client’s separation and enrichment work is valuable for advancing biomolecule characterization and disease-relevant research. One recommender stated that:
“In our opinion, [Client’s] research successes and publication history undeniably demonstrate the invaluable asset which [Client] represents to the nation.”
With the evidence organized around the endeavor’s national importance, the client’s demonstrated record of research progress, and independent reliance reflected in citations, USCIS approved the NIW petition. We are proud to have supported this successful outcome and look forward to the client’s continued contributions to analytical chemistry innovations that strengthen biomedical research and disease diagnosis in the United States.

